April 2022

Meet Our Latest KL2 Career Development Awardees

Congratulations to the latest cohort of KL2 Career Development Awardees funded by the UR CTSI! This year’s awardees will adapt a behavioral therapy for Deaf individuals, test a new treatment regimen for breast cancer patients with brain metastases, map brain pathways to aid surgery, and use artificial intelligence to support clinical decision making. 

National Study: Early Treatment with COVID Convalescent Plasma Prevents Hospitalization

The UR CTSI was part of a national study published in the New England Journal of Medicine showing that plasma from patients who have recovered from COVID is a safe and effective early outpatient treatment for others with the disease.